Clinical trial · Observational
Prospective Cohort With Hemopathy in Languedoc-Roussillon
Prospective Cohort Study of Clinical and Laboratory Data of Patients With Hemopathy in Languedoc-Roussillon
NCT02134574CI-TRIAL-00115337HemoDiagrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prospective Cohort Study of clinical and laboratory data of patients with hemopathy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematologic Malignancy | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| hematologic malignancy | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- hematologic malignancy
- description
- hematologic malignancy with a sampling of blood
- interventionNames
- Biological: hematologic malignancy
Primary outcomes (1)
- measure
- Survival with 2 years
- timeFrame
- 2 years
- description
- Prospective Cohort Study of clinical and biological data Analysis Biological, clinical and questionnaire EORTC\_QLQ-C30
Secondary outcomes (2)
- measure
- Survival with 5 years
- timeFrame
- 5 years
- description
- Prospective Cohort Study of clinical and biological data Analysis Biological, clinical and questionnaire EORTC\_QLQ-C30
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria: * Age over 18 * Consultant or hospitalized patient for suspected malignant hemopathy and justifying further exploration or patient with a diagnosis of malignant hemopathy less than 6 months old at the time of signing the consent * Having signed an informed consent * Affiliated with a social security scheme Exclusion criteria: * Minor or major protected * Patients who have received treatment for hematological pathology
References
Publications (0)
Data not yet available
No reference posted for this study.